Neuro NTK Logo

Neuro NTK

Neuro NTK header image

1. Summary

Ranks

Liquidity
-
Developer
-
Social
47
Momentum (beta)
0
Stack Rank™
-
Price
$0.000252660000 0.0%
Market Cap
$145,550.00 (#6823)
Supply
/
Price
52W High price $0.01
52W High date 7th Sep 2022 (2 years ago)
All Time High (ATH) Date 13th May 2025 (1 month ago)
All Time Low (ATL) Date 13th May 2025 (1 month ago)
Supply & Trading Volume
Description

Overview

Overview

Neuro NTK (NeuroToolKit) is a collaborative project between academia and industry aimed at advancing research and informating developments in diagnostic and treatment solutions for Alzheimer’s disease, neurodegeneration, and other neurological disorders. The initiative focuses on generating high-quality, reproducible, and comparable clinical biomarker data to accelerate the validation of biomarkers for clinical utility.

Core Components

  • Biomarker Assays: The NTK offers a comprehensive portfolio of prototype assays that measure biomarkers across CSF and serum/plasma platforms. The assays are designed for use on the fully automated Elecsys platform in qualified NTK labs, ensuring high-quality, reproducible data.

  • NTKApp: A cloud-based analytics platform that improves the interpretation of neurologically relevant immunoassay data. It provides users with a unified environment to upload, curate, analyze, and compare biomarker datasets and results. Additionally, users can import and run their own statistical analysis pipelines, which can be shared with the NTK community.

  • Data Analysis and Collaboration: The NTK enables collaborative research by providing a robust digital research environment, facilitating the sharing and interpretation of data across various cohorts. This collaboration accelerates the discovery and development of biomarkers suitable for clinical trials and routine medical practice.

  • ADDI NeuroToolKit Data Hackathon: A virtual event that brings together researchers, clinicians, data scientists, and biostatisticians to explore the clinical utility of biomarkers in Alzheimer’s disease. Participants use the NTKApp, EPAD datasets, and statistical analysis tools available on the AD Workbench to explore standardized and customized analyses.

Goals and Future Directions

  • Clinical Utility and Validation: Clarify the clinical utility of biomarkers in Alzheimer’s disease and other neurological disorders

  • IVD Development: Inform the development of In Vitro Diagnostics (IVD) biomarkers that support clinical screening, diagnosis, prognosis, and drug monitoring

  • Partnerships and Expansion: Encourage collaboration among partners, including academia and industry, to accelerate biomarker research and development.

2. Price

2.1. Market Performance

How does Neuro NTK's () performance compare to the median performance for assets of a similar market capitalization?

30 Day Return

%

-23.3%

Similar Market Cap

3. Developer Activity

No GitHub repos found. Either the project is not open source or we don't have data yet.

4. Social Activity

Tip: Toggle each network by clicking the name above

Historic data is only available from 22nd April 2022

Total Followers

Reddit Subscribers 1,246
Active Reddit Users (past 24h) 3
Discord users
Active Discord Users
Telegram Users
Twitter followers 4,816
5. News

No recent news found.

7. More Information

Always do your own research (DYOR) before making any investment. Here's some links you might find helpful:

Website https://neuromation.io/
Explorer https://etherscan.io/token/0x69beab403438253f13b6e...
Twitter @neuromation_io
reddit /r/Neuromation

What is the correct contract address for Neuro NTK?

Ethereum 0x69beab403438253f13b6e92db91f7fb849258263

Has Neuro NTK been audited for security?

No security audits found for this project.

Are you the owner of Neuro NTK? Edit it here

Subscribe for free

Investment alerts and insights directly in your inbox.

By continuing, you agree to the Stack Terms of Service and Privacy Policy.